UY31205A1 - Composiciones de tabletas de desintegracion oral de lamotrigina - Google Patents
Composiciones de tabletas de desintegracion oral de lamotriginaInfo
- Publication number
- UY31205A1 UY31205A1 UY31205A UY31205A UY31205A1 UY 31205 A1 UY31205 A1 UY 31205A1 UY 31205 A UY31205 A UY 31205A UY 31205 A UY31205 A UY 31205A UY 31205 A1 UY31205 A1 UY 31205A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions
- lamotrigin
- oral disintegration
- disintegration tablets
- patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composiciones que comprenden una cantidad eficaz para uso terapéutico de partículas que comprenden lamotrigina, en combinacion con gránulos que comprenden un desintegrante, y un alcohol de azucar y/o un hidrato de carbono. Estas composiciones son utiles para el tratamiento de la epilepsia y el trastorno bipolar, particularmente para pacientes con disfagia, y para mejorar la conformidad en pacientes con trastorno bipolar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92953607P | 2007-07-02 | 2007-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31205A1 true UY31205A1 (es) | 2008-11-28 |
Family
ID=40226529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31205A UY31205A1 (es) | 2007-07-02 | 2008-07-02 | Composiciones de tabletas de desintegracion oral de lamotrigina |
Country Status (15)
Country | Link |
---|---|
US (5) | US7919115B2 (es) |
EP (1) | EP2173172A4 (es) |
JP (2) | JP5346021B2 (es) |
CN (2) | CN101801192B (es) |
AR (1) | AR068185A1 (es) |
AU (1) | AU2008272871B2 (es) |
BR (1) | BRPI0814408A2 (es) |
CA (1) | CA2693072C (es) |
CL (1) | CL2008001966A1 (es) |
HK (2) | HK1147026A1 (es) |
NZ (1) | NZ582458A (es) |
SA (1) | SA08290401B1 (es) |
TW (1) | TWI547282B (es) |
UY (1) | UY31205A1 (es) |
WO (1) | WO2009006516A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108348460A (zh) * | 2015-09-11 | 2018-07-31 | 安德鲁·吉斯 | 一种口服颗粒组合物 |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
TWI547282B (zh) | 2007-07-02 | 2016-09-01 | 愛戴爾製藥股份有限公司 | 樂命達之口服分解錠劑組合物 |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
CN101842085B (zh) * | 2007-10-31 | 2013-01-30 | 麦克内尔-Ppc股份有限公司 | 口腔崩解剂型 |
US20090196924A1 (en) * | 2008-02-04 | 2009-08-06 | Pramod Kharwade | Controlled-release lamotrigine formulations |
TWI406679B (zh) * | 2009-06-06 | 2013-09-01 | Bio Trend Pharmaceutical Co Ltd | 含高劑量活性物質之口崩錠 |
US20110097401A1 (en) * | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
US20110070286A1 (en) * | 2009-09-24 | 2011-03-24 | Andreas Hugerth | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
US9610224B2 (en) * | 2009-09-24 | 2017-04-04 | Johnson & Johnson Consumer Inc. | Manufacture of tablet in a die utilizing powder blend containing water-containing material |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
SG10201407965XA (en) * | 2009-12-02 | 2015-02-27 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
US20120282335A1 (en) * | 2010-12-02 | 2012-11-08 | Aptalis Pharmatech Inc. | Rapidly dispersing granules, orally disintegrating tablets and methods |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US20140322296A1 (en) * | 2013-03-22 | 2014-10-30 | Aptalis Pharma S.R.L. | Piperaquine microcapsules and compositions containing them |
JP2015063521A (ja) * | 2013-09-02 | 2015-04-09 | 科研製薬株式会社 | 高い薬物含有率を有する錠剤及びその製造方法 |
MX368159B (es) | 2014-01-10 | 2019-09-20 | Johnson & Johnson Consumer Inc | Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas. |
FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
CN104473895A (zh) * | 2014-11-20 | 2015-04-01 | 美吉斯制药(厦门)有限公司 | 拉莫三嗪口腔崩解缓释片 |
CN104645336B (zh) * | 2015-01-04 | 2017-08-29 | 深圳市药品检验研究院 | 一种复合辅料及其制备方法和用途 |
CN104622825A (zh) * | 2015-02-09 | 2015-05-20 | 鲁南贝特制药有限公司 | 一种阿奇霉素分散片 |
CN104940128A (zh) * | 2015-05-31 | 2015-09-30 | 黑龙江佰彤儿童药物研究有限公司 | 一种拉莫三嗪口服液体制剂及其制备方法 |
WO2017017679A1 (en) * | 2015-07-29 | 2017-02-02 | Dexcel Pharma Technologies Ltd. | Compositions comprising atorvastatin or a pharmaceutically acceptable salt thereof |
CN109562075A (zh) * | 2016-07-05 | 2019-04-02 | 葛兰素史克消费保健(美国)控股有限责任公司 | 包含快速释放外包衣的口服剂型 |
CN107625786A (zh) * | 2016-07-18 | 2018-01-26 | 北京科信必成医药科技发展有限公司 | 一种碳酸钙维生素d3组合物及其无水吞服颗粒 |
CN107625734B (zh) * | 2016-07-19 | 2022-02-18 | 北京科信必成医药科技发展有限公司 | 一种无水吞服掩味制剂及其制备方法 |
WO2018021265A1 (ja) | 2016-07-27 | 2018-02-01 | 沢井製薬株式会社 | 口腔内崩壊錠添加用組成物 |
JP6651638B2 (ja) * | 2016-09-06 | 2020-02-19 | 沢井製薬株式会社 | 口腔内崩壊錠添加用組成物 |
US20180256515A1 (en) | 2017-03-10 | 2018-09-13 | Adare Pharmaceuticals, Inc. | Oral amphetamine composition |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
US20200214985A1 (en) * | 2017-08-21 | 2020-07-09 | Nipro Corporation | Pharmaceutical composition particles, orally disintegrating preparation containing same, and method for producing pharmaceutical composition particles |
TWI826474B (zh) * | 2018-06-27 | 2023-12-21 | 日商第一三共股份有限公司 | 包含二胺衍生物之顆粒劑、以及其用途及製造方法 |
IL295007A (en) | 2020-01-31 | 2022-09-01 | Nanocopoeia Llc | Amorphous nilotinib microparticles and uses thereof |
WO2021222739A1 (en) | 2020-04-30 | 2021-11-04 | Nanocopoeia, Llc | Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib |
WO2022008966A1 (en) * | 2020-07-06 | 2022-01-13 | Reema Sinha | N - [4 - (trifluoromethoxy) benzylidene) nicotinohydrazide composition for oral administration |
CN113456603A (zh) * | 2021-07-02 | 2021-10-01 | 安徽省先锋制药有限公司 | 一种拉莫三嗪分散片的制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL9220009A (nl) * | 1991-01-30 | 1993-11-01 | Wellcome Found | In water-dispergeerbare tabletten. |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
AU722289B2 (en) | 1996-10-01 | 2000-07-27 | Aptalis Pharmatech, Inc. | Taste-masked microcapsule compositions and methods of manufacture |
US7939102B2 (en) | 2002-06-07 | 2011-05-10 | Torrent Pharmaceuticals Ltd. | Controlled release formulation of lamotrigine |
ES2199061B1 (es) * | 2002-06-10 | 2005-02-16 | Laboratorios Vita, S.A. | Comprimidos bucodispersables y procedimiento para su obtencion. |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
WO2004103340A1 (en) | 2003-05-20 | 2004-12-02 | Ranbaxy Laboratories Limited | Water dispersible tablets of lamotrigine |
US20050096311A1 (en) * | 2003-10-30 | 2005-05-05 | Cns Response | Compositions and methods for treatment of nervous system disorders |
AU2005244329A1 (en) * | 2004-04-06 | 2005-11-24 | Rpg Life Sciences Limited | Mouth dissolvable and meltable, and water dispersable delivery formulation |
US8545881B2 (en) * | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
CA2584957C (en) * | 2004-10-21 | 2015-08-25 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US20060182796A1 (en) * | 2005-02-03 | 2006-08-17 | Abrika Pharmaceuticals, Inc. | Taste masked pharmaceutical compositions |
IS7724A (is) * | 2005-03-02 | 2006-09-03 | Actavis Group | Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat |
EP1978933A2 (en) * | 2005-12-15 | 2008-10-15 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for oral administration |
US7919155B2 (en) * | 2007-03-07 | 2011-04-05 | Xerox Corporation | Document and method of making document including invisible information for security applications |
TWI547282B (zh) * | 2007-07-02 | 2016-09-01 | 愛戴爾製藥股份有限公司 | 樂命達之口服分解錠劑組合物 |
-
2008
- 2008-07-01 TW TW097124814A patent/TWI547282B/zh active
- 2008-07-02 EP EP08772352A patent/EP2173172A4/en not_active Withdrawn
- 2008-07-02 CL CL2008001966A patent/CL2008001966A1/es unknown
- 2008-07-02 SA SA08290401A patent/SA08290401B1/ar unknown
- 2008-07-02 NZ NZ582458A patent/NZ582458A/xx not_active IP Right Cessation
- 2008-07-02 BR BRPI0814408A patent/BRPI0814408A2/pt not_active Application Discontinuation
- 2008-07-02 AU AU2008272871A patent/AU2008272871B2/en not_active Ceased
- 2008-07-02 UY UY31205A patent/UY31205A1/es not_active Application Discontinuation
- 2008-07-02 AR ARP080102871A patent/AR068185A1/es unknown
- 2008-07-02 JP JP2010515251A patent/JP5346021B2/ja active Active
- 2008-07-02 WO PCT/US2008/069000 patent/WO2009006516A1/en active Application Filing
- 2008-07-02 US US12/166,757 patent/US7919115B2/en not_active Expired - Fee Related
- 2008-07-02 CN CN200880105269.9A patent/CN101801192B/zh active Active
- 2008-07-02 CA CA2693072A patent/CA2693072C/en not_active Expired - Fee Related
- 2008-07-02 CN CN201410249690.4A patent/CN104161733A/zh active Pending
-
2009
- 2009-12-01 US US12/628,677 patent/US8647656B2/en active Active
-
2011
- 2011-01-31 HK HK11100987.2A patent/HK1147026A1/xx not_active IP Right Cessation
-
2012
- 2012-04-25 US US13/455,942 patent/US8840925B2/en active Active
-
2013
- 2013-08-15 JP JP2013168951A patent/JP2013241462A/ja active Pending
-
2014
- 2014-02-05 US US14/172,962 patent/US9339504B2/en not_active Expired - Fee Related
-
2015
- 2015-03-09 HK HK15102347.9A patent/HK1201745A1/xx unknown
-
2016
- 2016-05-16 US US15/155,960 patent/US20160256464A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108348460A (zh) * | 2015-09-11 | 2018-07-31 | 安德鲁·吉斯 | 一种口服颗粒组合物 |
Also Published As
Publication number | Publication date |
---|---|
EP2173172A4 (en) | 2012-11-07 |
CN101801192A (zh) | 2010-08-11 |
TWI547282B (zh) | 2016-09-01 |
AU2008272871B2 (en) | 2014-08-07 |
US20090092672A1 (en) | 2009-04-09 |
NZ582458A (en) | 2012-09-28 |
JP5346021B2 (ja) | 2013-11-20 |
US20140220144A1 (en) | 2014-08-07 |
US20130108703A1 (en) | 2013-05-02 |
EP2173172A1 (en) | 2010-04-14 |
WO2009006516A1 (en) | 2009-01-08 |
HK1147026A1 (en) | 2011-07-22 |
US8840925B2 (en) | 2014-09-23 |
US7919115B2 (en) | 2011-04-05 |
BRPI0814408A2 (pt) | 2017-05-09 |
AR068185A1 (es) | 2009-11-11 |
US8647656B2 (en) | 2014-02-11 |
JP2010532384A (ja) | 2010-10-07 |
JP2013241462A (ja) | 2013-12-05 |
CA2693072C (en) | 2016-09-06 |
US9339504B2 (en) | 2016-05-17 |
US20100303905A1 (en) | 2010-12-02 |
CA2693072A1 (en) | 2009-01-08 |
SA08290401B1 (ar) | 2013-12-10 |
CN101801192B (zh) | 2014-07-02 |
TW200911267A (en) | 2009-03-16 |
US20160256464A1 (en) | 2016-09-08 |
CL2008001966A1 (es) | 2009-03-20 |
CN104161733A (zh) | 2014-11-26 |
AU2008272871A1 (en) | 2009-01-08 |
HK1201745A1 (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31205A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
AR069875A1 (es) | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion | |
CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
CL2008001855A1 (es) | Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa. | |
PL385586A1 (pl) | Nowe analogi insuliny o przedłużonym działaniu | |
AR089509A1 (es) | Metodo para tratar la perdida osea alveolar, un implante dental, un anticuerpo antiesclerostina, un gel o matriz que comprende dicho anticuerpo y uso | |
PA8637201A1 (es) | Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa | |
UY30359A1 (es) | Coterapeutica para el tratamiento de epilepsia y trastornos relacionados i | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
AR071728A1 (es) | Terapia con intervalos para el tratamiento del tinnitus | |
ZA200807879B (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
CO6311006A2 (es) | Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+ efectiva a dosis altas | |
AR060580A1 (es) | Elastomeros de silicona que contienen antisepticos | |
CL2007002875A1 (es) | Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales. | |
UY29777A1 (es) | Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión. | |
EA200970483A1 (ru) | Применение пролекарств габапентина и прегабалина для лечения шума в ушах | |
TW200630128A (en) | Active ingredient-containing silicone elastomers | |
NZ628513A (en) | Pharmaceutical for oral delivery comprising mgbg and methods of treating disease | |
CO6771406A2 (es) | Una composición combinada | |
BR112016028446A2 (pt) | inibidor de complemento de ornithodoros moubata para uso no tratamento de doenças mediadas por complemento em pacientes com polimorfismo de c5 | |
CL2015001180A1 (es) | Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos. | |
AR072951A1 (es) | Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre | |
UY30065A1 (es) | Composiciones farmacéuticas para la erradicación de helicobacter pylori | |
CL2010001594A1 (es) | Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida. | |
AR068815A1 (es) | Soporte para corona dental provisional |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20200115 |